Semaglutide 5mg - Third-Party Test Results
Manufacturer: LeoLab™
Sample: Semaglutide 5mg
Date: 07 OCT 2025
On September 30, 2025, LeoLab submitted a 5 mg sample of Semaglutide (Batch S60088) for independent third-party analysis by Janosik Analytical, a leading laboratory specializing in pharmaceutical quality testing. The sample was received on October 3, 2025, and the testing was registered under Task Number #81941. The analysis assessed purity, identity, and mass content to ensure accuracy and compliance with high research standards.
Test Summary:
-
Peptide Tested: Semaglutide
-
Batch Number: S60088
-
Nominal Quantity: 5 mg
-
Measured Mass: 5.79 mg
-
Purity: 99.328%
Review:
The independent analysis conducted by Janosik Analytical confirmed a high purity level of 99.328 %, which aligns with strict industry and research standards. This indicates that the Semaglutide peptide is of excellent quality, containing minimal impurities and suitable for precise and sensitive laboratory applications.
The measured mass of 5.79 mg demonstrates excellent labeling accuracy, ensuring that the delivered product matches the advertised amount. Additionally, the identity testing confirmed that the peptide corresponds exactly to the expected molecular structure of Semaglutide, verifying authenticity and consistency.
Purity 99.328%
Mass 5.79 mg
